Since NOD2 signaling is protective in IBD, MDP administration protects mice from DSS-induced colitis and this protective effect of MDP is lost in mice with defective NOD2 signaling (Bertrand et al, 2009; Watanabe et al, 2008). Here, NOD2 is linked to inflammatory bowel disease.